Larimar Therapeutics Inc. buy Quitte
Start price
04.10.16
/
50%
€37.88
Target price
31.01.17
€44.38
Performance (%)
17.14%
End price
31.01.17
€44.38
Summary
This prediction ended on 31.01.17 with a price of €44.38. The BUY prediction by Quitte finished with a performance of 17.14%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | -4.317% | -4.317% | -14.744% | -34.158% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% | 63.672% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% | 109.562% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% | 54.912% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% | 69.801% |
Comments by Quitte for this prediction
In the thread Zafgen Inc. diskutieren